Drug Target Review Issue 2 2019
In this issue: novel approaches to produce radiolabelled antibodies, the use of CRISPR/Cas9 to accelerate the development of targeted therapies and utilisation of stem cells to study the effects of cannabis on neuronal development.
Included in this issue:
Radiochemistry and drug synthesis ‘in a flash’
Professor Dr Jason P. Holland, University of Zurich, Switzerland
- MASS SPECTROMETRY
Bringing native analysis into the fast-moving world of biologics
Christopher Nortcliffe, Applications Specialist, LC/MS Biologics and Biopharma, SCIEX
Phenotypic profiling in drug discovery
Sean Lin, Ina Rothenaigner, Kamyar Hadian
High-content imaging: challenges of the 3D world
Margaritha M. Mysior and Jeremy C. Simpson, UCD Cell Screening Laboratory, School of Biology & Environmental Science, University College Dublin, Ireland
- STEM CELLS
Stem-cell technologies in immunotherapy
Aparajita DubeyAssociate Scientific Manager, Biocon Biologics Limited, Bangalore, India
The rest of this content is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- quarterly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!